VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Granisetron and dexamethasone
Phase 3
Small molecule
G
Guangxi Medical University
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Vomiting
1 trial
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
Unknown status
·
G
Guangxi Medical University
·
Phase 3
·
NCT05711823
·
300 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Granisetron and dexamethasone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Granisetron and dexamethasone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Granisetron and dexamethasone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Guangxi Medical University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
G
Guangxi Medical University
Related News